Evidence map›Paper›PMID 35128027›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2022

Cognitive practice effects delay diagnosis of MCI: Implications for clinical trials.

Mark Sanderson-Cimino, Jeremy A Elman, Xin M Tu, Alden L Gross, Matthew S Panizzon, Daniel E Gustavson, Mark W Bondi, Emily C Edmonds, Graham M L Eglit, Joel S Eppig and 7 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Evaluating practice effects across learning trials - ceiling effects or something more?Journal of clinical and experimental neuropsychology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Concordance Between Logical Memory and Craft Story 21 in Community-Dwelling Older Adults: The Role of Demographic Factors And Cognitive Status.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2023
    Article
  13. Pragmatic approaches to handling practice effects in longitudinal cognitive aging research.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Mark Sanderson-CiminoSan Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology San Diego California USA.
Jeremy A ElmanCenter for Behavior Genetics of Aging University of California San Diego La Jolla California USA.
Xin M TuDepartment of Psychiatry School of Medicine University of California San Diego La Jolla California USA.
Alden L GrossDepartment of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA.
Matthew S PanizzonCenter for Behavior Genetics of Aging University of California San Diego La Jolla California USA.
Daniel E GustavsonDepartment of Medicine Vanderbilt University Medical Center Nashville Tennessee USA.
Mark W BondiDepartment of Psychiatry School of Medicine University of California San Diego La Jolla California USA.
Emily C EdmondsDepartment of Psychiatry School of Medicine University of California San Diego La Jolla California USA.
Graham M L EglitCenter for Behavior Genetics of Aging University of California San Diego La Jolla California USA.
Joel S EppigVA Puget Sound Seattle Division Seattle Washington USA.
Carol E FranzCenter for Behavior Genetics of Aging University of California San Diego La Jolla California USA.
Amy J JakCenter for Behavior Genetics of Aging University of California San Diego La Jolla California USA.
Michael J LyonsDepartment of Psychological and Brain Sciences Boston University Boston Massachusetts USA.
Kelsey R ThomasDepartment of Psychiatry School of Medicine University of California San Diego La Jolla California USA.
McKenna E WilliamsSan Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology San Diego California USA.
William S KremenCenter for Behavior Genetics of Aging University of California San Diego La Jolla California USA.
Alzheimer's Disease Neuroimaging Initiative
University of California, San Diego · USBoston University · USJohns Hopkins University · USSan Diego State University · USVanderbilt University Medical Center · USVA Puget Sound Health Care System · USVA San Diego Healthcare System · US

Funding

UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Steven Dyal Edland · 2019 to 2026
$34.9M
Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI Corinne Pettigrew · 2020 to 2026
$29.3M
The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 4)R01AG050595 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELMAN, JEREMY A, FRANZ, CAROL ELAINE · 2015 to 2024
$28.0M
The VETSA Longitudinal MRI Twin Study of AgingR01AG022381 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KREMEN, WILLIAM S. · 2003 to 2019
$22.3M
Urban Air Pollution and Pathological Brain Aging: A Nationwide Twin Study in MenP01AG055367 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHEN, JIU-CHIUAN · 2018 to 2022
$11.5M
Remote Data Enclave Core (RDEC)P30AG066587 · NIA · JOHNS HOPKINS UNIVERSITY · PI DANIEL E POLSKY, Jennifer L. Wolff · 2020 to 2026
$6.7M
Linking genetic subtypes of Alzheimer's disease to biological and cognitive heterogeneityK01AG063805 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELMAN, JEREMY A · 2021 to 2024
$516k
NIA NIH HHS K01 AG063805NIA NIH HHS P01 AG055367NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG066507NIA NIH HHS P30 AG066587NIA NIH HHS R01 AG022381NIA NIH HHS R01 AG050595
6 · The paper itself

Abstract

introductionPractice effects (PEs) on cognitive tests obscure decline, thereby delaying detection of mild cognitive impairment (MCI). Importantly, PEs may be present even when there are performance declines, if scores would have been even lower without prior test exposure. We assessed how accounting for PEs using a replacement-participants method impacts incident MCI diagnosis.

methodsOf 889 baseline cognitively normal (CN) Alzheimer's Disease Neuroimaging Initiative (ADNI) participants, 722 returned 1 year later (mean age = 74.9 ± 6.8 at baseline). The scores of test-naïve demographically matched "replacement" participants who took tests for the first time were compared to returnee scores at follow-up. PEs-calculated as the difference between returnee follow-up scores and replacement participants scores-were subtracted from follow-up scores of returnees. PE-adjusted cognitive scores were then used to determine if individuals were below the impairment threshold for MCI. Cerebrospinal fluid amyloid beta, phosphorylated tau, and total tau were used for criterion validation. In addition, based on screening and recruitment numbers from a clinical trial of amyloid-positive individuals, we estimated the effect of earlier detection of MCI by accounting for cognitive PEs on a hypothetical clinical trial in which the key outcome was progression to MCI.

resultsIn the ADNI sample, PE-adjusted scores increased MCI incidence by 19% ( DISCUSSION: Detecting MCI as early as possible is of obvious importance. Accounting for cognitive PEs with the replacement-participants method leads to earlier detection of MCI, improved diagnostic accuracy, and can lead to multi-million-dollar cost reductions for clinical trials.

Indexed as

Alzheimer's diseaseclinical trialsearly diagnosislongitudinal agingmild cognitive impairmentpractice effects

Identifiers

PMID35128027
PMCPMC8804942
OpenAlexW4210398604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.